Using CRISPR/Cas9 gene editing technology, investigators have developed a method that may reveal the functions of regulatory elements in the human genome that do not code for proteins but have critical roles in health and disease.
Adapted from a bacterial host-defense system, CRISPR (clustered, regularly interspaced, palindromic repeats) uses the DNA-cutting enzyme Cas9 bound to a short RNA guide strand that can be tailored to home to a specific genetic sequence. In a recent Nature Biotechnologystudy, researchers at Duke University used a modified version of this system to target DNA sequences that don’t encode genes but rather dictate if and when particular genes will be expressed.
Hampton T. CRISPR-Based System Uncovers Key Regulators of Disease-Related Genes. JAMA. 2017;318(5):412–413. doi:10.1001/jama.2017.9216
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: